Company Profiles

driven by the PitchBook Platform

FasTraQ

FasTraQ
2002 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Conv. Debt LATEST DEAL TYPE
$3.2M LATEST DEAL AMOUNT
Description

Developer of blood diagnosis solutions to the healthcare industry. The company's product, FasTraQ ER-CPC Platform, allow users to perform pregnancy and cardiac tests.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
3028 Stratmoor Hills Avenue
Henderson, NV 89052
United States

+1 (702) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore FasTraQ’s full profile, request a free trial.

FasTraQ Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Convertible Debt 08-Dec-2006 $3.2M 000.00 Completed Startup
2. Early Stage VC (Series B) 21-Mar-2005 000.00 000.00 Completed Startup
1. Early Stage VC (Series A) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

FasTraQ Executive Team (2)

Name Title Board
Seat
Contact
Info
Robert Case Chief Executive Officer & President

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com